The brain is the body's control center, so when a disease affects it, the outcomes are devastating. Alzheimer's and Parkinson's disease, and multiple sclerosis are brain diseases that cause a large number of human deaths worldwide. Curcumin has demonstrated beneficial effects on brain health through several mechanisms such as antioxidant, amyloid β-binding, anti-inflammatory, tau inhibition, metal chelation, neurogenesis activity, and synaptogenesis promotion. The therapeutic limitation of curcumin is its bioavailability, and to address this problem, new nanoformulations are being developed. The present review aims to summarize the general bioactivity of curcumin in neurological disorders, how functional molecules are extracted, and the different types of nanoformulations available.

Curcumin's Nanomedicine Formulations for Therapeutic Application in Neurological Diseases / B. Salehi, D. Calina, A.O. Docea, N. Koirala, S. Aryal, D. Lombardo, L. Pasqua, Y. Taheri, C. Marina Salgado Castillo, M. Martorell, N. Martins, M. Iriti, H.A.R. Suleria, J. Sharifi-Rad. - In: JOURNAL OF CLINICAL MEDICINE. - ISSN 2077-0383. - 9:2(2020 Feb 05).

Curcumin's Nanomedicine Formulations for Therapeutic Application in Neurological Diseases

M. Iriti;
2020

Abstract

The brain is the body's control center, so when a disease affects it, the outcomes are devastating. Alzheimer's and Parkinson's disease, and multiple sclerosis are brain diseases that cause a large number of human deaths worldwide. Curcumin has demonstrated beneficial effects on brain health through several mechanisms such as antioxidant, amyloid β-binding, anti-inflammatory, tau inhibition, metal chelation, neurogenesis activity, and synaptogenesis promotion. The therapeutic limitation of curcumin is its bioavailability, and to address this problem, new nanoformulations are being developed. The present review aims to summarize the general bioactivity of curcumin in neurological disorders, how functional molecules are extracted, and the different types of nanoformulations available.
curcumin; liposomes; nanocarriers; nanocurcumin; neurological disorders
Settore AGR/12 - Patologia Vegetale
5-feb-2020
Article (author)
File in questo prodotto:
File Dimensione Formato  
jcm-09-00430-v2.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 4.46 MB
Formato Adobe PDF
4.46 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/769779
Citazioni
  • ???jsp.display-item.citation.pmc??? 59
  • Scopus 120
  • ???jsp.display-item.citation.isi??? 105
social impact